User profiles for Joanna Rorbach
Joanna RorbachKarolinska Institutet Verified email at ki.se Cited by 3898 |
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease
Known disease mechanisms in mitochondrial DNA (mtDNA) maintenance disorders alter
either the mitochondrial replication machinery (POLG, POLG2 and C10orf2) 1 , 2 , 3 or the …
either the mitochondrial replication machinery (POLG, POLG2 and C10orf2) 1 , 2 , 3 or the …
[HTML][HTML] Distinct pre-initiation steps in human mitochondrial translation
…, O Yukhnovets, H Höfig, A Amunts, J Rorbach - Nature …, 2020 - nature.com
Translation initiation in human mitochondria relies upon specialized mitoribosomes and
initiation factors, mtIF2 and mtIF3, which have diverged from their bacterial counterparts. Here …
initiation factors, mtIF2 and mtIF3, which have diverged from their bacterial counterparts. Here …
Structures of the human mitochondrial ribosome in native states of assembly
Mammalian mitochondrial ribosomes (mitoribosomes) have less rRNA content and 36 additional
proteins compared with the evolutionarily related bacterial ribosome. These differences …
proteins compared with the evolutionarily related bacterial ribosome. These differences …
Mitochondrially targeted ZFN s for selective degradation of pathogenic mitochondrial genomes bearing large‐scale deletions or point mutations
PA Gammage, J Rorbach, AI Vincent… - EMBO molecular …, 2014 - embopress.org
We designed and engineered mitochondrially targeted obligate heterodimeric zinc finger
nucleases (mt ZFN s) for site‐specific elimination of pathogenic human mitochondrial DNA (mt …
nucleases (mt ZFN s) for site‐specific elimination of pathogenic human mitochondrial DNA (mt …
A functional peptidyl‐tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome
Bioinformatic analysis classifies the human protein encoded by immature colon carcinoma
transcript‐1 (ICT1) as one of a family of four putative mitochondrial translation release factors. …
transcript‐1 (ICT1) as one of a family of four putative mitochondrial translation release factors. …
[HTML][HTML] Deficient methylation and formylation of mt-tRNAMet wobble cytosine in a patient carrying mutations in NSUN3
Epitranscriptome modifications are required for structure and function of RNA and defects in
these pathways have been associated with human disease. Here we identify the RNA target …
these pathways have been associated with human disease. Here we identify the RNA target …
[PDF][PDF] ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy
The human mitochondrial genome encodes RNA components of its own translational
machinery to produce the 13 mitochondrial-encoded subunits of the respiratory chain. Nuclear-…
machinery to produce the 13 mitochondrial-encoded subunits of the respiratory chain. Nuclear-…
[HTML][HTML] mtRF1a is a human mitochondrial translation release factor decoding the major termination codons UAA and UAG
Human mitochondria contain their own genome, encoding 13 polypeptides that are
synthesized within the organelle. The molecular processes that govern and facilitate this …
synthesized within the organelle. The molecular processes that govern and facilitate this …
The post-transcriptional life of mammalian mitochondrial RNA
Mammalian mitochondria contain their own genome that encodes mRNAs for thirteen
essential subunits of the complexes performing oxidative phosporylation as well as the RNA …
essential subunits of the complexes performing oxidative phosporylation as well as the RNA …
[PDF][PDF] Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy
R Kopajtich, TJ Nicholls, J Rorbach… - The American Journal of …, 2014 - cell.com
Respiratory chain deficiencies exhibit a wide variety of clinical phenotypes resulting from
defective mitochondrial energy production through oxidative phosphorylation. These defects …
defective mitochondrial energy production through oxidative phosphorylation. These defects …